药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tenocyclidine
Vitespen
The therapeutic efficacy of Vitespen can be decreased when used in combination with Ozanimod.
Tenocyclidine
GI-5005
The therapeutic efficacy of GI-5005 can be decreased when used in combination with Ozanimod.
Tenocyclidine
SRP 299
The therapeutic efficacy of SRP 299 can be decreased when used in combination with Ozanimod.
Tenocyclidine
Rindopepimut
The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Ozanimod.
Tenocyclidine
INGN 225
The therapeutic efficacy of INGN 225 can be decreased when used in combination with Ozanimod.
Tenocyclidine
PEV3A
The therapeutic efficacy of PEV3A can be decreased when used in combination with Ozanimod.
Tenocyclidine
G17DT
The therapeutic efficacy of G17DT can be decreased when used in combination with Ozanimod.
Tenocyclidine
Tofacitinib
Ozanimod may increase the immunosuppressive activities of Tofacitinib.
Tenocyclidine
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Ozanimod.
Tenocyclidine
Roflumilast
Roflumilast may increase the immunosuppressive activities of Ozanimod.
Tenocyclidine
Difluocortolone
The risk or severity of adverse effects can be increased when Difluocortolone is combined with Ozanimod.
Tenocyclidine
Clobetasol
The risk or severity of adverse effects can be increased when Clobetasol is combined with Ozanimod.
Tenocyclidine
Fluocortolone
The risk or severity of adverse effects can be increased when Fluocortolone is combined with Ozanimod.
Tenocyclidine
Hydrocortisone butyrate
The risk or severity of adverse effects can be increased when Ozanimod is combined with Hydrocortisone butyrate.
Tenocyclidine
Ocrelizumab
The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Ozanimod.
Tenocyclidine
Bleselumab
The risk or severity of adverse effects can be increased when Ozanimod is combined with Bleselumab.
Tenocyclidine
Rozanolixizumab
The risk or severity of adverse effects can be increased when Ozanimod is combined with Rozanolixizumab.
Tenocyclidine
Risankizumab
The risk or severity of adverse effects can be increased when Ozanimod is combined with Risankizumab.
Tenocyclidine
Emapalumab
The risk or severity of adverse effects can be increased when Ozanimod is combined with Emapalumab.
Tenocyclidine
Hydrocortisone succinate
The risk or severity of adverse effects can be increased when Ozanimod is combined with Hydrocortisone succinate.